Intracranial Pressure Monitoring in Sever Traumatic Brain Injury Single Center Experience
Launched by ASSIUT UNIVERSITY · Oct 24, 2018
Trial Information
Current as of May 15, 2025
Unknown status
Keywords
ClinConnect Summary
ICP \>15 mmHg is considered to be elevated, and this is considered an important cause of secondary injury leading to irreversible brain injury and death. ICP monitoring is used in a number of conditions; traumatic brain injury, intracerebral haemorrhage, subarachnoid haemorrhage, hydrocephalus, malignant infarction, cerebral oedema, CNS infections, hepatic encephalopathy, to name a few, and in all of these conditions ICP monitoring in the light of other parameters can influence management for better outcomes.
There are 4 ways to monitor intracranial pressure:
1. An intra-parenchymal metho...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Age \>18
- • 2. GCS \< 8
- • 3. patient with severe brain insult ( Marshall class II to IV)
- • 4. patients admitted within 24 hours from the trauma time
- Exclusion Criteria:
- • 1. Patients admitted for surgery (ex; surgical EDH) .
- • 2. patient diagnosed as brain death
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials